Vallon Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vallon Pharmaceuticals generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $10,797,000 last year. Net change in cash is therefore $1,799,000.
Cash Flow
| 2018 | -2.37M | -2.20K | 2.98M |
|---|---|---|---|
| 2019 | -2.88M | 0 | 6.09M |
| 2020 | -3.70M | -2K | -4K |
| 2021 | -8.31M | -3.84M | 15.74M |
| 2022 | -7.13M | 3.78M | 3.43M |
| 2023 | 0 | -8K | 10.79M |
VLON Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 9K | 3.70M | 109K | 3.82M | 612.65K | 0 |
Operating activities | ||||||
Net income | -13.03M | -7.02M | -9.30M | -4.82M | -3.46M | -4.31M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 4K | 206K | 73K | 75K | 15.73K | 612 |
Stock-based compensation expense | 388K | 99K | 626K | 154K | 80.12K | 51.15K |
| Deferred income tax benefit | 388K | 99K | 626K | 154K | 80.12K | 51.15K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.15M | -95K | -308K | 980K | -40.28K | 286.61K |
Cash generated by operating activities | 0 | -7.13M | -8.31M | -3.70M | -2.88M | -2.37M |
Investing activities | ||||||
Purchases Of Investments | 0 | -640K | -3.84M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -8K | 0 | 0 | -2K | 0 | -2.20K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -8K | 3.78M | -3.84M | -2K | 0 | -2.20K |
Financing activities | ||||||
Common Stock Issued | 12.25M | 3.44M | 15.10M | 0 | 4.98M | 2.98M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -106K | -65K | 0 | -190K |
Cash used in financing activities | 10.79M | 3.43M | 15.74M | -4K | 6.09M | 2.98M |
Net Change In Cash | 1.79M | 79K | 3.59M | -3.71M | 3.20M | 612.65K |
Cash at end of period | 1.80M | 3.78M | 3.70M | 109K | 3.82M | 612.65K |
| Data source | Data source | Data source | Data source |